Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
IgA nephropathy type 3 is an autosomal dominant disorder caused by mutations of the SPRY2 gene.
IgA nephropathy
|
||||
|
CFHR1
|
|||
|
|
CFHR3
|
|||
|
|
CFHR5
|
|||
|
|
IgA nephropathy type 1
|
|||
|
|
IgA nephropathy type 2
|
|||
|
IgA nephropathy type 3
|
|||
|
|
|
SPRY2
|
||
|
|
|
|
|
| 1. |
Milillo A et al. (2015) A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. 
|
| 2. |
OMIM.ORG article Omim 616818
|
 |
Copyright © 2005-2025 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944 Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits |